Clinical Trials in Goyang-si, Gyeonggi-do
2 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer1,006 enrolled154 locationsNCT04389632
Recruiting
Phase 3
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Recurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7Cardiotoxicity+2 more
SWOG Cancer Research Network491 enrolled590 locationsNCT03418961
Recruiting
Phase 1Phase 2
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Eli Lilly and Company540 enrolled49 locationsNCT04956640
Recruiting
Phase 4
Viscum Album for TNBC on Adjuvant Pembrolizumab
Breast Cancer
Ilsan Cha hospital40 enrolled1 locationNCT06920810
Recruiting
Not Applicable
Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy
Breast CancerBreast Neoplasms
National Cancer Center, Korea128 enrolled1 locationNCT06780735
Recruiting
Phase 1Phase 2
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Head and Neck CancerMalignant Melanoma
GeneMedicine Co., Ltd.125 enrolled4 locationsNCT06265025